首页> 外文会议>International Conference on Applied Sciences, Engineering and Technology >l-stepholidine, a naturally occurring dopamine D1 receptor agonist and D2 receptor antagonist, attenuates methamphetamine self-administration in rate
【24h】

l-stepholidine, a naturally occurring dopamine D1 receptor agonist and D2 receptor antagonist, attenuates methamphetamine self-administration in rate

机译:L- StepHolidine,天然存在的多巴胺D1受体激动剂和D2受体拮抗剂,衰减甲基苯丙胺自我管理

获取原文

摘要

Given the problems associated with the escalation in methamphetamine (METH) use, the identification of more effective treatment strategies is essential, l-stepholidine (l-SPD) is an alkaloid extract of the Chinese herb Stephania intermedia with dopamine Dl receptor partial agonistic and D2 receptor antagonistic dual actions. The unique pharmacological profile of l-SPD suggests that l-SPD may be effective for the treatment of METH addiction. The aim of this study was to characterize the effect ofl -SPD on METH self-administration on a fixed-ratio 1 schedule. We found that 5 and 10 mg/kg of l-SPD attenuated METH self-administration behavior. These results demonstrate that l-SPD which possesses dual actions on dopamine Dl and D2 receptors, attenuates METH self-administration on a fixed-ratio 1 schedule.
机译:鉴于与甲基苯丙胺(甲基)使用中升级相关的问题,鉴定更有效的治疗策略是必需的,L- Stepholidine(L-SPD)是中草药斯蒂芬血症中介多巴胺DL受体部分激动和D2的生物碱提取物受体对抗双重行动。 L-SPD的独特药理学曲线表明L-SPD可有效治疗甲状腺素。本研究的目的是表征-SPD对固定比例的甲基自我施用的影响。我们发现5和10mg / kg的L-SPD减弱了甲基自我管理行为。这些结果表明,具有在多巴胺D1和D2受体上具有双重作用的L-SPD,衰减甲基自我给予固定比例1时分。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号